Operating profit/loss of Symphogen 2008-2018
The Danish biotechnology company Symphogen made operating losses during all years from 2008 to 2018. The largest operating loss was in 2016, at around 434 million Danish kroner. In 2018, the losses were a little smaller, of around 378 million Danish kroner.